BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22495382)

  • 1. DOG1 (clone K9) is seldom expressed and not useful in the evaluation of pancreatic neoplasms.
    Hemminger J; Marsh WL; Iwenofu OH; Frankel WL
    Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):397-401. PubMed ID: 22495382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic expression of DOG1: a novel gastrointestinal stromal tumor (GIST) biomarker.
    Ardeleanu C; Arsene D; Hinescu M; Andrei F; Gutu D; Luca L; Popescu LM
    Appl Immunohistochem Mol Morphol; 2009 Oct; 17(5):413-8. PubMed ID: 19417627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovered on gastrointestinal stromal tumours 1 (DOG1) expression in non-gastrointestinal stromal tumour (GIST) neoplasms.
    Hemminger J; Iwenofu OH
    Histopathology; 2012 Aug; 61(2):170-7. PubMed ID: 22571292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of DOG1 immunohistochemistry in dermatopathology.
    Goto K
    J Cutan Pathol; 2016 Nov; 43(11):974-983. PubMed ID: 27506854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
    Miettinen M; Wang ZF; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DOG1 for the diagnosis of gastrointestinal stromal tumor (GIST): Comparison between 2 different antibodies.
    Lopes LF; West RB; Bacchi LM; van de Rijn M; Bacchi CE
    Appl Immunohistochem Mol Morphol; 2010 Jul; 18(4):333-7. PubMed ID: 20571340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse pancreatic serous cystadenoma associated with neuroendocrine carcinoma: a case report and review of literature.
    Agarwal N; Kumar S; Dass J; Arora VK; Rathi V
    JOP; 2009 Jan; 10(1):55-8. PubMed ID: 19129617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DOG1 Expression in Low-Grade Fibromyxoid Sarcoma: A Study of 11 Cases, With Molecular Characterization.
    Thway K; Ng W; Benson C; Chapman J; Fisher C
    Int J Surg Pathol; 2015 Sep; 23(6):454-60. PubMed ID: 26135531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas.
    Abd Raboh NM; Hakim SA
    Int J Clin Exp Pathol; 2015; 8(8):9214-22. PubMed ID: 26464669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calponin is expressed in serous cystadenomas of the pancreas but not in adenocarcinomas or endocrine tumors.
    Marsh WL; Colonna J; Yearsley M; Bloomston M; Frankel WL
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):216-9. PubMed ID: 19391217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine-needle aspirations of pancreatic serous cystadenomas: improving diagnostic yield with cell blocks and α-inhibin immunohistochemistry.
    Salomao M; Remotti H; Allendorf JD; Poneros JM; Sethi A; Gonda TA; Saqi A
    Cancer Cytopathol; 2014 Jan; 122(1):33-9. PubMed ID: 23939868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is DOG1 Immunoreactivity Specific to Gastrointestinal Stromal Tumor?
    Swalchick W; Shamekh R; Bui MM
    Cancer Control; 2015 Oct; 22(4):498-504. PubMed ID: 26678977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paranuclear dot-like immunostaining for CD99: a unique staining pattern for diagnosing solid-pseudopapillary neoplasm of the pancreas.
    Guo Y; Yuan F; Deng H; Wang HF; Jin XL; Xiao JC
    Am J Surg Pathol; 2011 Jun; 35(6):799-806. PubMed ID: 21566515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of dog1 in low-grade fibromyxoid sarcoma: A study of 19 cases and review of the literature.
    Vallejo-Benítez A; Rodríguez-Zarco E; Carrasco SP; Pereira-Gallardo S; Brugal Molina J; García-Escudero A; Robles Frías A; Marcilla D; González-Cámpora R
    Ann Diagn Pathol; 2017 Oct; 30():8-11. PubMed ID: 28965630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical localization of metallothionein and p53 protein in pancreatic serous cystadenomas.
    Sliwińska-Mossoń M; Milnerowicz H; Rabczyński J; Milnerowicz S
    Arch Immunol Ther Exp (Warsz); 2009; 57(4):295-301. PubMed ID: 19578815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovered on gastrointestinal stromal tumour 1 (DOG1): a useful immunohistochemical marker for diagnosing chondroblastoma.
    Akpalo H; Lange C; Zustin J
    Histopathology; 2012 Jun; 60(7):1099-106. PubMed ID: 22335248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is DOG1 really useful in the diagnosis of salivary gland acinic cell carcinoma? - A DOG1 (clone K9) analysis in fine needle aspiration cell blocks and the review of the literature.
    Canberk S; Onenerk M; Sayman E; Goret CC; Erkan M; Atasoy T; Kilicoglu GZ
    Cytojournal; 2015; 12():18. PubMed ID: 26425134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DOG1 immunoreactivity in uterine leiomyosarcomas.
    Sah SP; McCluggage WG
    J Clin Pathol; 2013 Jan; 66(1):40-3. PubMed ID: 23038686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Use for DOG1 in Discriminating Breast Invasive Carcinoma from Noninvasive Breast Lesions.
    Cheng H; Yang S; Qu Z; Zhou S; Ruan Q
    Dis Markers; 2016; 2016():5628176. PubMed ID: 27041791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic endocrine tumor coexistent with serous microcystic adenoma: report of a case and review of the literature.
    Alasio TM; Vine A; Sanchez MA; Dardik H
    Ann Diagn Pathol; 2005 Aug; 9(4):234-8. PubMed ID: 16084460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.